Insider · CIK 0001369091

VERNON W ANTHONY

Reports to the SEC for 9 companies · WAYNE, PA

sec.gov

Transactions

Companies

Filings

CIK

0001369091

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-03	NVCRNovoCure LtdA Award	Director	AAward	+11.6K sh	—	—	209,267
2026-06-03	NVCRNovoCure Ltd · Stock Option (Right to Buy)A Award	Director	AAward	+17K sh	—	—	16,999
2026-06-02	NVCRNovoCure LtdS Sale	Director	SSale	−2,945 sh	$15.77	−$46.4K	197,657
2026-05-21	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+123K sh	—	—	123,397
2026-04-28	NVCRNovoCure LtdM Exercise/Conversion	Director	MExercise/Conversion	+21.5K sh	$11.39	+$245K	200,602
2026-04-28	NVCRNovoCure Ltd · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−21.5K sh	—	—	0
2026-02-15	MKCMCCORMICK & CO INCM Exercise/Conversion	Director	MExercise/Conversion	+2,222 sh	—	—	14,048
2026-02-15	MKCMCCORMICK & CO INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,222 sh	—	—	0
2025-06-04	NVCRNovoCure LtdA Award	Director	AAward	+11.2K sh	—	—	179,102
2025-06-04	NVCRNovoCure Ltd · Stock Option (Right to Buy)A Award	Director	AAward	+16.7K sh	—	—	16,697
2025-06-03	NVCRNovoCure LtdS Sale	Director	SSale	−999 sh	$17.35	−$17.3K	167,887
2025-05-21	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+293K sh	—	—	292,983
2025-03-15	MKCMCCORMICK & CO INCM Exercise/Conversion	Director	MExercise/Conversion	+1,344 sh	—	—	11,826
2025-03-15	MKCMCCORMICK & CO INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,344 sh	—	—	0
2025-02-07	MKCMCCORMICK & CO INC · Restricted Stock UnitsA Award	Director	AAward	+2,222 sh	—	—	2,222
2024-09-03	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+201K sh	—	—	200,801
2024-06-05	NVCRNovoCure LtdA Award	Director	AAward	+4,053 sh	—	—	169,850
2024-06-05	NVCRNovoCure Ltd · Stock Option (Right to Buy)A Award	Director	AAward	+6,229 sh	—	—	6,229
2024-06-04	NVCRNovoCure LtdS Sale	Director	SSale	−964 sh	$23.89	−$23K	164,833
2024-03-27	MKCMCCORMICK & CO INC · Restricted Stock UnitsA Award	Director	AAward	+1,344 sh	—	—	1,344
2024-03-27	MKCMCCORMICK & CO INC · Options - Right to BuyA Award	Director	AAward	+3,732 sh	—	—	3,732
2024-03-15	MKCMCCORMICK & CO INCM Exercise/Conversion	Director	MExercise/Conversion	+1,255 sh	—	—	10,482
2024-03-15	MKCMCCORMICK & CO INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,255 sh	—	—	0
2023-06-07	NVCRNovoCure LtdA Award	Director	AAward	+3,853 sh	—	—	165,797
2023-06-07	NVCRNovoCure Ltd · Stock Option (Right to Buy)A Award	Director	AAward	+6,277 sh	—	—	6,277
2023-05-15	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+367K sh	—	—	366,744
2023-03-29	MKCMCCORMICK & CO INC · Restricted Stock UnitsA Award	Director	AAward	+1,255 sh	—	—	1,255
2023-03-29	MKCMCCORMICK & CO INC · Options- Right to BuyA Award	Director	AAward	+3,101 sh	—	—	3,101
2023-03-15	MKCMCCORMICK & CO INCM Exercise/Conversion	Director	MExercise/Conversion	+1,044 sh	—	—	9,227
2023-03-15	MKCMCCORMICK & CO INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,044 sh	—	—	0
2022-06-08	NVCRNovoCure Ltd · Options to Buy Ordinary SharesA Award	Director	AAward	+8,700 sh	—	—	8,700
2022-05-16	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+119K sh	—	—	118,784
2022-05-16	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+141K sh	—	—	140,713
2022-03-30	MKCMCCORMICK & CO INC · Restricted Stock UnitsA Award	Director	AAward	+1,044 sh	—	—	1,044
2022-03-30	MKCMCCORMICK & CO INC · Options- Right to BuyA Award	Director	AAward	+2,711 sh	—	—	2,711
2022-03-15	MKCMCCORMICK & CO INCM Exercise/Conversion	Director	MExercise/Conversion	+1,139 sh	—	—	8,183
2022-03-15	MKCMCCORMICK & CO INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,139 sh	—	—	0
2021-10-29	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+45.2K sh	—	—	45,229
2021-06-09	NVCRNovoCure LtdA Award	Director	AAward	+814 sh	—	—	161,944
2021-06-09	NVCRNovoCure Ltd · Options to Buy Ordinary SharesA Award	Director	AAward	+1,499 sh	—	—	1,499
2021-03-31	MKCMCCORMICK & CO INC · Restricted Stock UnitsA Award	Director	AAward	+1,156 sh	—	—	1,156
2021-03-31	MKCMCCORMICK & CO INC · Options - Right to BuyA Award	Director	AAward	+3,268 sh	—	—	3,268
2021-03-15	MKCMCCORMICK & CO INCM Exercise/Conversion	Director	MExercise/Conversion	+1,468 sh	—	—	7,044
2021-03-15	MKCMCCORMICK & CO INC · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,468 sh	—	—	0
2021-02-10	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+51.7K sh	—	—	51,703
2021-02-10	NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+188K sh	—	—	187,658
2020-06-10	NVCRNovoCure LtdA Award	Director	AAward	+2,541 sh	—	—	161,130
2020-06-10	NVCRNovoCure Ltd · Options to Buy Ordinary SharesA Award	Director	AAward	+5,101 sh	—	—	5,101
2020-06-04	Intersect ENT, Inc.A Award	Director	AAward	+5,011 sh	—	—	11,383
2020-06-04	Intersect ENT, Inc.Stock Option (right to buy)A Award	Director	AAward	+9,666 sh	—	—	9,666

Recent filings

Accepted (ET)
Jun 54
VERNON W ANTHONY0001369091-26-000005
SEC(opens sec.gov)
Jun 34
VERNON W ANTHONY0001369091-26-000004
SEC(opens sec.gov)
May 264
VERNON W ANTHONY0001369091-26-000003
SEC(opens sec.gov)
Apr 284
VERNON W ANTHONY0001369091-26-000002
SEC(opens sec.gov)
Feb 184
VERNON W ANTHONY0000063754-26-000123
SEC(opens sec.gov)
Jun 64
VERNON W ANTHONY0001562180-25-004555
SEC(opens sec.gov)
Jun 44
VERNON W ANTHONY0001562180-25-004429
SEC(opens sec.gov)
May 234
VERNON W ANTHONY0001415889-25-014421
SEC(opens sec.gov)
Mar 184
VERNON W ANTHONY0001062993-25-005760
SEC(opens sec.gov)
Feb 144
VERNON W ANTHONY0001062993-25-002439
SEC(opens sec.gov)
Sep 54
VERNON W ANTHONY0001415889-24-022968
SEC(opens sec.gov)
Jun 64
VERNON W ANTHONY0001562180-24-004761
SEC(opens sec.gov)
Mar 294
VERNON W ANTHONY0001062993-24-007430
SEC(opens sec.gov)

Companies

Address

C/O NOVOCURE INC. 1550 LIBERTY RIDGE DRIVE, SUITE 115

WAYNE, PA, 19087